Home » Authors » Kim Coghill

Articles by Kim Coghill

Focused On Brain, CNS Disorders, Saegis Raises $30M In Its Series B

Nov. 19, 2003

Phoenix Pharmacologics Starts Phase III Study In Liver Cancer

Nov. 19, 2003

Allos Presents RSR13 Data; NDA Completion Expected This Year

Nov. 18, 2003

Allos Presents RSR13 Data; NDA Completion Expected This Year

Nov. 18, 2003

U.S. Federal Survey Probes Biotech Growth, Hindrances

Nov. 17, 2003

Dendreon Regains Asian Provenge Rights From Kirin, Avoids IP Issues

Nov. 17, 2003

Dendreon Regains Asian Provenge Rights From Kirin, Avoids IP Issues

Nov. 17, 2003

U.S. Federal Survey Probes Biotech Growth, Hindrances

Nov. 17, 2003

Preparing For Estrasorb Launch, Novavax Publicly Raises $27.7M

Nov. 14, 2003

Preparing For Estrasorb Launch, Novavax Publicly Raises $27.7M

Nov. 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026